Does Colistin-Meropenem combination therapy reduce the emergence of colistin resistance vs. Colistin monotherapy? ( Dickstein Y. et al. & AIDA study group. )
Colistin Resistance Development Following Colistin-Meropenem Combination Therapy vs. Colistin Monotherapy in Patients with Infections Caused by Carbapenem-Resistant Organisms.
| Dr Jean-Pierre Bru Colistin is one of a limited number of options for the treatment of carbapenem-resistant Gram-negative bacteria. A previously published randomized … Suite